{"doi":"10.3390/ijerph191710837","title":"Consumption of JUUL vs. Other E-Cigarette Brands among U.S. E-Cigarette Users: Evidence from Wave 5 of the PATH Study","abstract":"This study examines the use of JUUL vs. other e-cigarette brands among U.S. youth (12-17 years), young adult (18-24 years), and adult (25 years and above) e-cigarette users. Data were from the Population Assessment of Tobacco and Health (PATH) study Wave 5 survey (2019). The study population was past 30-day e-cigarette users who knew the brand of e-cigarettes they usually/last used (N = 2569). JUUL use was reported by 65.2% of youth, 60.7% of young adult, and 25.6% of adult e-cigarette users in our study sample. The share of JUUL consumed in the past 30 days, measured by the total number of puffs, was 15.4% by youth, 55.5% by young adults, and 29.1% by adults. By contrast, the share of other e-cigarettes consumed was 4.2% by youth, 28.9% by young adults, and 66.9% by adults. Youth JUUL users were more likely to use e-cigarettes within 30 min after waking (aOR = 2.30, 95% CI: 1.12-4.75) than youth users of other brands of e-cigarettes. Additionally, youth e-cigarette users who currently smoked cigarettes were less likely to use JUUL (aOR = 0.55, 95% CI: 0.30-0.99). This study concludes that JUUL consumption was disproportionally higher among youth and young adults in the U.S. in 2019.","journal":"International Journal of Environmental Research and Public Health","year":2022,"id":260142,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":16,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.8914,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":381331,"name":"Zongshuan Duan","orcid":"0000-0002-2598-1752","position":1,"is_corresponding":false},{"id":380434,"name":"Scott R. Weaver","orcid":"0000-0003-3155-4041","position":2,"is_corresponding":false},{"id":406344,"name":"Lucy Popova","orcid":"0000-0002-3450-4579","position":3,"is_corresponding":false},{"id":380433,"name":"Claire A. Spears","orcid":"0000-0002-7869-5661","position":4,"is_corresponding":false},{"id":380432,"name":"David L. Ashley","orcid":"0000-0002-1060-5893","position":5,"is_corresponding":false},{"id":404936,"name":"Terry F. Pechacek","orcid":"0000-0003-4887-1254","position":6,"is_corresponding":false},{"id":380436,"name":"Michael P. Eriksen","orcid":"0000-0002-0136-0978","position":7,"is_corresponding":false},{"id":380435,"name":"Jidong Huang","orcid":"0000-0002-3425-9155","position":8,"is_corresponding":false},{"id":381330,"name":"Yu Wang","orcid":"0000-0002-1481-5329","position":0,"is_corresponding":true}],"reference_count":57,"raw_metadata":null,"created_at":"2026-07-19T00:26:03.189798Z","pmid":"36078551","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}